Hodgkin Lymphoma
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | CD30 + | Hodgkin Lymphoma | Brentuximab Vedotin, Dacarbazine, Doxorubicin, Vinblastine | |
| Sensitivity (+) | CD30 + | Hodgkin Lymphoma | Brentuximab Vedotin | |
| Sensitivity (+) | CD30 + | Hodgkin Lymphoma | Brentuximab Vedotin |